title: [The treatment of obstructive hypertrophic myocardiopathy refractory to medical therapy].
abstract: Until a few years ago, therapy of refractory Hypertrophic Obstructive cardiomyopathy was mainly surgical--Morrow's myotomy/myectomy or mitral valve replacement. Despite the good results of these techniques, they are not free of mortality and morbidity. In the last years a new and promising therapy has been developed: the Dual Chamber Pacemaker. Technically easier and less invasive than surgery, this therapy has achieved better results and lower mortality and morbidity during the follow-up.
authors.affiliation: Serviço de Cardiologia, Hospital de Pulido Valente, Lisboa.
authors.forename: N
authors.initials: N
authors.lastname: Cardim
authors.forename: S
authors.initials: S
authors.lastname: Longo
authors.forename: D
authors.initials: D
authors.lastname: Gouveia
authors.forename: N
authors.initials: N
authors.lastname: Lousada
authors.forename: M
authors.initials: M
authors.lastname: Rodrigues
authors.forename: T
authors.initials: T
authors.lastname: Ferreira
authors.forename: A T
authors.initials: AT
authors.lastname: Pereira
authors.forename: J M
authors.initials: JM
authors.lastname: Correia
mesh_terms: D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy*; D006346:Heart Septum / Q000601:surgery; D006350:Heart Valve Prosthesis; D006801:Humans; D008943:Mitral Valve; D010138:Pacemaker, Artificial
vernacular_title: Terapêutica da miocardiopatia hipertrófica obstrutiva refractária à terapêutica médica.